The world’s Largest Sharp Brain Virtual Experts Marketplace Just a click Away
Levels Tought:
Elementary,Middle School,High School,College,University,PHD
| Teaching Since: | May 2017 |
| Last Sign in: | 399 Weeks Ago |
| Questions Answered: | 66690 |
| Tutorials Posted: | 66688 |
MCS,PHD
Argosy University/ Phoniex University/
Nov-2005 - Oct-2011
Professor
Phoniex University
Oct-2001 - Nov-2016
9.11 Many consumer groups feel that the U.S. Food andDrug Administration (FDA) drug approval process is tooeasy and, as a result, too many drugs are approved that arelater found to be unsafe. On the other hand, a number ofindustry lobbyists have pushed for a more lenient approvalprocess so that pharmaceutical companies can get newdrugs approved more easily and quickly. Consider a nullhypothesis that a new, unapproved drug is unsafe and analternative hypothesis that a new, unapproved drug is safe.a. explain the risks of committing a type I or type II error.b. Which type of error are the consumer groups trying toavoid? explain.c. Which type of error are the industry lobbyists trying toavoid? explain.d. How would it be possible to lower the chances of bothtype I and type II errors?
Hel-----------lo -----------Sir-----------/Ma-----------dam-----------Tha-----------nk -----------You----------- fo-----------r u-----------sin-----------g o-----------ur -----------web-----------sit-----------e a-----------nd -----------acq-----------uis-----------iti-----------on -----------of -----------my -----------pos-----------ted----------- so-----------lut-----------ion-----------.Pl-----------eas-----------e p-----------ing----------- me----------- on-----------cha-----------t I----------- am----------- on-----------lin-----------e o-----------r i-----------nbo-----------x m-----------e a----------- me-----------ssa-----------ge -----------I w-----------ill----------- be-----------